PT3698630T - Administração e monitorização de óxido nítrico em fluidos ex vivo - Google Patents

Administração e monitorização de óxido nítrico em fluidos ex vivo

Info

Publication number
PT3698630T
PT3698630T PT201698115T PT20169811T PT3698630T PT 3698630 T PT3698630 T PT 3698630T PT 201698115 T PT201698115 T PT 201698115T PT 20169811 T PT20169811 T PT 20169811T PT 3698630 T PT3698630 T PT 3698630T
Authority
PT
Portugal
Prior art keywords
administration
monitoring
nitric oxide
vivo fluids
vivo
Prior art date
Application number
PT201698115T
Other languages
English (en)
Original Assignee
Mallinckrodt Pharmaceuticals Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Pharmaceuticals Ireland Ltd filed Critical Mallinckrodt Pharmaceuticals Ireland Ltd
Publication of PT3698630T publication Critical patent/PT3698630T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0236—Mechanical aspects
    • A01N1/0242—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components
    • A01N1/0247—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components for perfusion, i.e. for circulating fluid through organs, blood vessels or other living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3623—Means for actively controlling temperature of blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
PT201698115T 2013-03-15 2014-12-01 Administração e monitorização de óxido nítrico em fluidos ex vivo PT3698630T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361787865P 2013-03-15 2013-03-15
US14/095,621 US9629358B2 (en) 2013-03-15 2013-12-03 Administration and monitoring of nitric oxide in ex vivo fluids

Publications (1)

Publication Number Publication Date
PT3698630T true PT3698630T (pt) 2024-05-31

Family

ID=51528684

Family Applications (1)

Application Number Title Priority Date Filing Date
PT201698115T PT3698630T (pt) 2013-03-15 2014-12-01 Administração e monitorização de óxido nítrico em fluidos ex vivo

Country Status (12)

Country Link
US (3) US9629358B2 (pt)
EP (2) EP3086638B1 (pt)
JP (2) JP6612231B2 (pt)
AU (3) AU2014357412B2 (pt)
CA (3) CA3135254C (pt)
DK (1) DK3698630T3 (pt)
ES (1) ES2805366T3 (pt)
FI (1) FI3698630T3 (pt)
MX (2) MX2016007057A (pt)
PL (1) PL3698630T3 (pt)
PT (1) PT3698630T (pt)
WO (1) WO2015084698A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
CN114375945A (zh) 2011-04-14 2022-04-22 特兰斯迈迪茨公司 用于供体肺的离体机器灌注的器官护理溶液
AU2015271799B2 (en) 2014-06-02 2019-07-11 Transmedics, Inc. Ex vivo organ care system
WO2016090498A1 (en) 2014-12-12 2016-06-16 Freed Darren Apparatus and method for organ perfusion
JP2019506259A (ja) * 2015-12-11 2019-03-07 ベロ バイオテック エルエルシー 線維症に対処するために一酸化窒素を含むガスを投与するための方法及び装置
EP3970730B1 (en) * 2016-02-12 2024-05-01 Mallinckrodt Pharmaceuticals Ireland Limited System for use and monitoring of inhaled nitric oxide with left ventricular assist devices
WO2017205967A1 (en) 2016-05-30 2017-12-07 Freed Darren Apparatus and method for ex vivo lung ventilation with a varying exterior pressure
US20180071467A1 (en) * 2016-09-10 2018-03-15 Geno Llc System and method for portable nitric oxide delivery
TWI656890B (zh) * 2017-07-12 2019-04-21 英屬開曼群島商怡忠國際有限公司 體外生命支持系統
MX2020001853A (es) * 2017-08-25 2020-08-03 Mallinckrodt Hospital Products Ip Ltd Métodos para mejorar la viabilidad de los órganos.
US11881119B2 (en) * 2017-12-06 2024-01-23 Cilag Gmbh International Modeling air leaks in lungs
GB2587350B (en) * 2019-09-23 2021-12-15 Royal Papworth Hospital Nhs Found Trust Organ perfusion system and method
GB2596041A (en) * 2020-03-26 2021-12-22 Univ Newcastle System and Method for Monitoring Body Tissue
CN113797404B (zh) * 2021-01-06 2023-05-09 郝云玲 一种向血液中补充一氧化氮（no）的装置
EP4137170A1 (en) 2021-07-29 2023-02-22 Tim Bast Purge fluid generator for membrane oxygenation
CN113975505B (zh) * 2021-11-08 2023-12-19 中山大学中山眼科中心 用于眼球灌注的体外循环系统

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338662A (en) 1992-09-21 1994-08-16 Bio-Preserve Medical Corporation Organ perfusion device
US5558083A (en) 1993-11-22 1996-09-24 Ohmeda Inc. Nitric oxide delivery system
US5725492A (en) * 1996-03-04 1998-03-10 Cormedics Corp Extracorporeal circulation apparatus and method
EP1712226A3 (en) * 1996-04-05 2007-03-21 The General Hospital Corporation Treatment of a Hemoglobinopathy
US5732693A (en) 1996-10-02 1998-03-31 Ohmeda Inc. Pause control of nitric oxide therapy
US5752504A (en) 1996-12-13 1998-05-19 Ohmeda Inc. System for monitoring therapy during calibration
US5885842A (en) * 1996-11-08 1999-03-23 Medinox, Inc. Methods for the detection of nitric oxide in fluid media
US6125846A (en) 1997-05-16 2000-10-03 Datex-Ohmeda, Inc. Purge system for nitric oxide administration apparatus
US7749693B2 (en) * 1998-09-29 2010-07-06 Lifeline Scientific, Inc. Method of determining that an organ is not suitable for transplantation and using it for testing substances
GB9908335D0 (en) * 1999-04-12 1999-06-09 Univ Cambridge Tech Methods and means for extracorporeal organ perfusion
US6314956B1 (en) * 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
JP4258908B2 (ja) * 1999-09-14 2009-04-30 株式会社ジェイ・エム・エス 人工肺装置
JP2001178817A (ja) * 1999-12-24 2001-07-03 Terumo Corp 人工腎臓用装置およびこれを用いた品質評価装置ならびに流体回路
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US6501974B2 (en) * 2001-01-22 2002-12-31 Datex-Ohmeda, Inc. Compensation of human variability in pulse oximetry
MXPA03012031A (es) 2001-06-21 2005-07-01 Univ Yale El monoxido de carbono mejoraresultados en transplantes de tejido y organo y suprime apoptosis.
US20040081580A1 (en) * 2002-09-10 2004-04-29 Doug Hole Use of nitric oxide and a device in the therapeutic management of pathogens in mammals
US7531133B2 (en) * 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US7274955B2 (en) * 2002-09-25 2007-09-25 Masimo Corporation Parameter compensated pulse oximeter
JP4352315B2 (ja) * 2002-10-31 2009-10-28 日本光電工業株式会社 信号処理方法／装置及びそれを用いたパルスフォトメータ
US7485324B2 (en) * 2003-09-29 2009-02-03 Pulmonox Technologies Corporation Use of exogenous gaseous nitric oxide in the treatment and disinfection of biofilms
CA2555552A1 (en) 2004-02-09 2005-09-09 Noxilizer, Inc. Nitric oxide-releasing molecules
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
ES2772676T3 (es) 2006-04-19 2020-07-08 Transmedics Inc Sistema de cuidado de órganos ex vivo
US10750738B2 (en) * 2008-01-31 2020-08-25 Transmedics, Inc. Systems and methods for ex vivo lung care
US9149646B2 (en) * 2008-12-31 2015-10-06 Koninklijke Philips N.V. Method and apparatus for controlling a process of injury therapy
US9278113B2 (en) 2009-03-30 2016-03-08 The Board Of Regents, The University Of Texas System Titanium dioxide nanotubes for production and delivery of nitric oxide and methods for production thereof
CA2671029A1 (en) 2009-06-30 2010-12-30 James S. Baldassarre Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
WO2011031289A1 (en) 2009-09-08 2011-03-17 Duke University Novel medical uses for no and no donor compounds
NZ739614A (en) 2011-01-06 2019-05-31 Mallinckrodt Hospital Products Ip Ltd Gas delivery device and system
MX362813B (es) 2011-11-07 2019-02-08 Mallinckrodt Hospital Products Ip Ltd Aparato y metodo para vigilar el suministro de oxido nitrico.
MX363507B (es) * 2012-05-31 2019-03-26 Mallinckrodt Hospital Products Ip Ltd Metodos para administrar óxido nítrico a la sangre arterial o arterializada.
AU2014243841A1 (en) * 2013-03-13 2015-11-05 Mallinckrodt Hospital Products IP Limited Devices and methods for monitoring oxygenation during treatment with delivery of nitric oxide

Also Published As

Publication number Publication date
AU2019246828B2 (en) 2021-12-02
US11291202B2 (en) 2022-04-05
JP2020033368A (ja) 2020-03-05
WO2015084698A2 (en) 2015-06-11
EP3698630A1 (en) 2020-08-26
CA2931943A1 (en) 2015-06-11
CA3135254A1 (en) 2015-06-11
AU2019246828A1 (en) 2019-11-07
AU2018203630A1 (en) 2018-06-21
PL3698630T3 (pl) 2024-08-05
DK3698630T3 (da) 2024-05-21
US20140272920A1 (en) 2014-09-18
EP3698630B1 (en) 2024-03-13
WO2015084698A3 (en) 2015-11-05
US20150093738A1 (en) 2015-04-02
JP6612231B2 (ja) 2019-11-27
AU2014357412A1 (en) 2016-06-16
JP6884190B2 (ja) 2021-06-09
CA3135254C (en) 2024-05-14
EP3086638A2 (en) 2016-11-02
US9629358B2 (en) 2017-04-25
MX2016007057A (es) 2017-02-02
MX2021001867A (es) 2021-04-19
AU2018203630B2 (en) 2019-08-29
FI3698630T3 (fi) 2024-05-24
ES2805366T3 (es) 2021-02-11
US20170215411A1 (en) 2017-08-03
AU2014357412B2 (en) 2018-03-01
EP3086638B1 (en) 2020-04-22
CA2931943C (en) 2021-11-30
JP2017503762A (ja) 2017-02-02
CA3233961A1 (en) 2015-06-11

Similar Documents

Publication Publication Date Title
PL3698630T3 (pl) Podawanie i monitorowanie poziomu tlenku azotu w płynach ex vivo
IL273829A (en) Mirogen biogenesis in the exosome for treatment and diagnosis
HK1220340A1 (zh) 用於在輸送氧化氮的治療過程中監測氧合作用的設備和方法
HK1223246A1 (zh) 疼痛藥物組合及其用途
HK1216251A1 (zh) 吡唑並吡咯烷衍生物及其治病作用
GB201522303D0 (en) Patient interface and aspects thereof
EP2968397A4 (en) DIAGNOSIS AND TREATMENT OF FIBROSIS
EP2967280A4 (en) MEDICAL IMAGING DEVICE AND METHODS OF USE
GB201421114D0 (en) Nitric oxide generator and inhaler
HK1217720A1 (zh) 選擇性遞送分子及使用方法
HK1222562A1 (zh) 用於醫學診斷的組合物及方法
EP3078666A4 (en) BORE-DIPYRROMETHENE FLUORESCENCE PROBES AND METHOD OF MANUFACTURE AND USE THEREOF
GB201306067D0 (en) Resuscitator arrangements and flow monitoring
HK1224234A1 (zh) 注射器以及注射器組件
PL3046946T3 (pl) Poliester i zastosowanie poliestru w środkach smarujących
EP2968309A4 (en) USE OF LEVOCETRIXIN AND MONTELUKAST IN THE TREATMENT OF VASCULARITY
EP3057645A4 (en) Preparation and delivery of sustained nitric oxide releasing solutions
EP2970154A4 (en) TETRAHYDROXAMATE CHELATORS OF ZIRCONIUM89 AND NIOBIUM90 FOR USE IN DIAGNOSTIC APPLICATIONS
EP2968758A4 (en) PRESCRIPTION OF PERFUSION AND COHERENCE OF ADMINISTRATION
GB201308753D0 (en) Compounds and their use in therapy
PT3086638T (pt) Processo de preservação de um pulmão para transplante usando óxido nítrico
GB201320958D0 (en) Improvements in and relating to medical devices
GB201312131D0 (en) Drug combination and its use in therapy
GB201312129D0 (en) Drug combination and its use in therapy
GB201312128D0 (en) Drug combination and its use in therapy